Confounding B-cell defences: Lessons from a staphylococcal superantigen

Nature Reviews Immunology

Volumn 6, Issue 6, 2006, Pages 465-475

  Silverman, Gregg J ^a   Goodyear, Carl S ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; AUTOANTIGEN; BACTERIAL ANTIGEN; CD40 LIGAND; ERYTHROCYTE MEMBRANE PROTEIN 1; FINGOLIMOD; GLYCOPROTEIN GP 120; HAPTEN; IMMUNOGLOBULIN G; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; STAPHYLOCOCCAL ENTEROTOXIN D; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; APOPTOSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BACTERIAL VIRULENCE; BONE MARROW; CELL DEATH; CELL MIGRATION; CHEMOTAXIS; CORRELATION ANALYSIS; CROSS LINKING; FETUS LIVER; GENE DELETION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL MEMBRANE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PEPTOSTREPTOCOCCUS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; HUMANS; IMMUNITY, CELLULAR; STAPHYLOCOCCAL PROTEIN A; SUPERANTIGENS;

EID: 33745698861     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1853     Document Type: Review

References (102)

1. Huber, B. T. Current Communications in Cell and Molecular Biology Vol. 182 (Cold Spring Harbor Laboratory Press, 1993).
2. Graille, M. et al. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc. Natl Acad. Sci. USA 97, 5399-5404 (2000). The first solved structure for a B-cell superantigen, also characterized in complex with an antibody.
3. Graille, M. et al. Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. Structure 9, 679-687 (2001).
4. Tutter, A. & Riblet, R. Conservation of an immunoglobulin variable-region gene family indicates a specific, noncoding function. Proc. Natl Acad. Sci. USA 86, 7460-7464 (1989).
5. Schroeder, H. W. J., Hillson, J. L. & Perlmutter, R. M. Structure and evolution of mammalian VH families. Int. Immunol. 2, 41-50 (1990).
6. H3 antibodies bind domain D of staphylococcal protein A. J. Immunol. 154, 6437-6446 (1995).
7. Silverman, G. J., Pirès, R. & Bouvet, J. P. An endogenous sialoprotein and a bacterial B-cell superantigen compete in their VH family-specific binding interactions with human immunoglobulins. J. Immunol. 157, 4496-4502 (1996).
8. Sasso, E. H., Silverman, G. J. & Mannik, M. Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J. Immunol. 142, 2778-2783 (1989). First demonstration of V-gene family restriction for the Fab-mediated binding interactions of SpA, which has become the prototypic B-cell superantigen.
9. Sasso, E. H., Silverman, G. J. & Mannik, M. Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup. J. Immunol. 147, 1877-1883 (1991).
10. H3 immunoglobulin binding to staphylococcal protein A. J. Exp. Med. 178, 331-336 (1993).
11. Sasano, M., Burton, D. R. & Silverman, G. J. Molecular selection of human antibodies with an unconventional bacterial B cell antigen. J. Immunol. 151, 5822-5839 (1993).
12. H3-restricted unconventional bacterial antigen. J. Immunol. 151, 5840-5855 (1993).
13. Bjorck, L. Protein L. A novel bacterial cell wall protein with affinity for Ig L chains. J. Immunol. 140, 1194-1197 (1988).
14. Beckingham, J. A., Bottomley, S. P., Hinton, R., Sutton, B. J. & Gore, M. G. Interactions between a single immunoglobulin-binding domain of protein L from Peptostreptococcus magnus and a human κ light chain. Biochem. J. 340, 193-199 (1999).
15. Axcrona, K., Bjorck, L. & Leanderson, T. Multiple ligand interactions for bacterial immunoglobulin-binding proteins on human and murine cells of the hematopoetic lineage. Scand. J. Immunol. 42, 359-367 (1995).
16. L-specific superantigen.
17. H3 gene products: natural ligands for HIV gp120. Science 261, 1588-1591 (1993). Prescient insights into the supraclonal-targeted properties of a B-cell superantigen expressed during systemic infection with HIV.
18. Goodglick, L., Zevit, N., Neshat, M. S. & Braun, J. Mapping the Ig superantigen-binding site of HIV-1 gp120. J. Immunol. 155, 5151-5159 (1995).
19. H3 Ig. Int. Immunol. 12, 305-312 (2000).
20. Karray, S. et al. Structural basis of the gp120 superantigen binding site on human immunoglobulins. J. Immunol. 161, 6681-6688 (1998).
21. Silverman, G. J., Roben, P., Bouvet, J.-P. & Sasano, M. Superantigen properties of a human sialoprotein involved in gut-associated immunity. J. Clin. Invest. 96, 417-426 (1995).
22. H4-expressing B cells from apoptosis. J. Immunol. 156, 3608-3620 (1996).
23. Donati, D. et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect. Immun. 72, 5412-5418 (2004).
24. Woof, J. M. The human IgA-Fc α receptor interaction and its blockade by streptococcal IgA-binding proteins. Biochem. Soc. Trans. 30, 491-494 (2002).
25. Sanders, J. D., Bastida-Corcuera, F. D., Arnold, K. F., Wunderlich, A. C. & Corbeil, L. B. Genetic manipulation of immunoglobulin binding proteins of Haemophilus somnus. Microb. Pathog. 34, 131-139 (2003).
26. Guo, M., Han, Y. W., Sharma, A. & De Nardin, E. Identification and characterization of human immunoglobulin G Fc receptors of Fusobacterium nucleatum. Oral Microbiol. Immunol. 15, 119-123 (2000).
27. 2 fragment. Infect. Immun. 68, 4786-4788 (2000).
28. Olsson, A. et al. Structure and evolution of the repetitive gene encoding streptococcal protein G. Eur. J. Biochem. 168, 319-324 (1987).
29. Ait-Azzouzene, D. et al. An immunoglobulin C κ-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system. J. Exp. Med. 201, 817-828 (2005).
30. Romagnani, S. et al. Demonstration on protein A of two distinct immunoglobulin-binding sites and their role in the mitogenic activity of Staphylococcus aureus Cowan I on human B cells. J. Immunol. 129, 596-602 (1982). Classic in vitro studies demonstrating the essential requirement for the B-cell superantigen-associated specificity of SpA for mitogenic properties.
31. Das, C. & Langone, J. J. Dissociation between murine spleen cell mitogenic activity of enterotoxin contaminants and anti-tumor activity of staphylococcal protein A. J. Immunol. 142, 2943-2948 (1989).
32. H3 mRNA expression by protein A-binding B cells. J. Clin. Immunol. 15, 145-151 (1995).
33. H3-expressing B lymphocytes. J. Immunol. 153, 2974-2984 (1994).
34. H-targeted apoptotic supraclonal B cell deletion by a Staphylococcal toxin. J. Exp. Med. 197, 1125-1139 (2003). Elucidation of primary pathways for activation-induced cell death that is induced by a B-cell superantigen.
35. Goodyear, C. S. & Silverman, G. J. Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proc. Natl Acad. Sci. USA 101, 11392-11397 (2004). Demonstration of preferential deletion of MZ B cells by SpA, which yields long-lasting functional immune defects.
36. Gray, D., Kumararatne, D. S., Lortan, J., Khan, M. & MacLennan, I. C. Relation of intra-splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells. Immunology 52, 659-669 (1984).
37. Groeneveld, P. H., Erich, T. & Kraal, G. In vivo effects of LPS on B lymphocyte subpopulations. Migration of marginal zone-lymphocytes and IgD-blast formation in the mouse spleen. Immunobiology 170, 402-411 (1985).
38. Liu, Y. J., Oldfield, S. & MacLennan, I. C. Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur. J. Immunol. 18, 355-362 (1988).
39. Vinuesa, C. G. et al. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation. Eur. J. Immunol. 31, 1340-1350 (2001).
40. Cinamon, G. et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nature Immunol. 5, 713-720 (2004).
41. Oliver, A. M., Martin, F., Gartland, G. L., Carter, R. H. & Kearney, J. F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27, 2366-2374 (1997).
42. Li, X., Martin, F., Oliver, A. M., Kearney, J. F. & Carter, R. H. Antigen receptor proximal signaling in splenic B-2 cell subsets. J. Immunol. 166, 3122-3129 (2001).
43. Lopes-Carvalho, T. & Kearney, J. F. Development and selection of marginal zone B cells. Immunol. Rev. 197, 192-205 (2004).
44. Verkoczy, L. K., Martensson, A. S. & Nemazee, D. The scope of receptor editing and its association with autoimmunity. Curr. Opin. Immunol. 16, 808-814 (2004).
45. Silverman, G. J. et al. A B cell superantigen-induced persistent 'hole' in the B-1 repertoire. J. Exp. Med. 192, 87-98 (2000). First demonstration of the special relationship between a superantigen and innate-like B cells.
46. Hao, Z. & Rajewsky, K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194, 1151-1164 (2001). Elegant demonstration of the different rates of turnover of mature B-cell subsets.
47. Pepys, M. B. Role of complement in the induction of immunological responses. Transplant Rev. 32, 93-120 (1976).
48. Heyman, B. The immune complex: possible ways of regulating the antibody response. Immunol. Today 11, 310-313 (1990).
49. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J. V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nature Immunol. 1, 31-36 (2000).
50. Pozdnyakova, O., Guttormsen, H. K., Lalani, F. N., Carroll, M. C. & Kasper, D. L. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J. Immunol. 170, 84-90 (2003).
51. Silverman, G. J. Adoptive transfer of a superantigen-induced 'hole' in the repertoire of natural IgM-secreting cells. Cell. Immunol. 209, 76-80 (2001).
52. + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17, 521-528 (1987).
53. Lalor, P. A., Herzenberg, L. A., Adams, S. & Stall, A. M. Feedback regulation of murine Ly-1 B cell development. Eur. J. Immunol. 19, 507-513 (1989).
54. Hayakawa, K., Hardy, R. R., Stall, A. M., Herzenberg, L. A. & Herzenberg, L. A. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol. 16, 1313-1316 (1986).
55. Hayakawa, K., Hardy, R. R., Herzenberg, L. A. & Herzenberg, L. A. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 161, 1554-1568 (1985).
56. Kantor, A. B., Stall, A. M., Adams, S., Watanabe, K. & Herzenberg, L. A. De novo development and self-replenishment of B cells. Int. Immunol. 7, 55-68 (1995).
57. Goodyear, C. S. & Silverman, G. J. B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies. Springer Semin. Immunopathol. 26, 463-484 (2005).
58. Viau, M., Cholley, B., Bjorck, L. & Zouali, M. Down-modulation of the antigen receptor by a superantigen for human B cells. Immunol. Lett. 92, 91-96 (2004).
59. Fruman, D. A., Satterthwaite, A. B. & Witte, O. N. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13, 1-3 (2000).
60. Chung, J. B., Sater, R. A., Fields, M. L., Erikson, J. & Monroe, J. G. CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int. Immunol. 14, 157-166 (2002).
61. Niiro, H. & Clark, E. A. Regulation of B-cell fate by antigen-receptor signals. Nature Rev. Immunol. 2, 945-956 (2002). Classic review of BCR-signalling pathways.
62. Shi, Y. F., Sahai, B. M. & Green, D. R. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339, 625-626 (1989).
63. Lenardo, M. et al. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221-253 (1999).
64. Hildeman, D. A., Zhu, Y., Mitchell, T. C., Kappler, J. & Marrack, P. Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 14, 354-359 (2002).
65. Strasser, A. The role of BH3-only proteins in the immune system. Nature Rev. Immunol. 5, 189-200 (2005).
66. Goodyear, C. S., Sugiyama, F. & Silverman, G. J. Temporal and dose-dependent relationships between in vivo B cell receptor-targeted proliferation and deletion-induced by a microbial B cell toxin. J. Immunol. 176, 2262-2271 (2006).
67. H family-restricted staphylococcal B-cell superantigen. J. Immunol. 161, 5720-5732 (1998).
68. Baumgarth, N., Herman, O. C., Jager, G. C., Brown, L. & Herzenberg, L. A. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl Acad. Sci. USA 96, 2250-2255 (1999).
69. Herzenberg, L. A. et al. The Ly-1 B cell lineage. Immunol Rev. 93, 81-102 (1986).
70. Viau, M., Longo, N. S., Lipsky, P. E. & Zouali, M. Staphylococcal protein a deletes B-1a and marginal zone B lymphocytes expressing human immunoglobulins: an immune evasion mechanism. J. Immunol. 175, 7719-7727 (2005).
71. H3 (D12 idiotope) B cells in vivo. J. Acquir. Immune. Defic. Syndr. 7, 641-646 (1994).
72. H3 gene repertoire of naive human B cells. J. Immunol. 164, 5482-5491 (2000).
73. Muller, S. et al. B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection. Scand. J. Immunol. 38, 327-334 (1993).
74. H3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons. J. Infect Dis. 181, 1313-1321 (2000).
75. Simberkoff, M. S., El Sadr, W., Schiffman, G. & Rahal, J. J. Jr. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am. Rev. Respir. Dis. 130, 1174-1176 (1984).
76. Grau, I. et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch. Intern. Med. 165, 1533-1540 (2005).
77. Badr, G. et al. HIV type 1 glycoprotein 120 inhibits human B cell chemotaxis to CXC chemokine ligand (CXCL) 12, CC chemokine ligand (CCL)20, and CCL21. J. Immunol. 175, 302-310 (2005).
78. Foster, T. J. The Staphylococcus aureus 'superbug'. J. Clin. Invest. 114, 1693-1696 (2004).
79. Palmqvist, N., Foster, T., Tarkowski, A. & Josefsson, E. Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb. Pathog. 33, 239-249 (2002).
80. Patel, A. H., Nowlan, P., Weavers, E. D. & Foster, T. Virulence of protein A-deficient and α-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55, 3103-3110 (1987).
81. Patella, V., Casolaro, V., Bjorck, L. & Marone, G. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells. J. Immunol. 145, 3054-3061 (1990).
82. H3 region of IgE to induce cytokine secretion from human basophils. Int. Arch. Allergy. Immunol. 118, 197-199 (1999).
83. H3 region of IgE. J. Immunol. 164, 589-595 (2000).
84. Kozlowski, L., Lambris, J. D., Silverman, G. J. & Levinson, A. Complement activation by a B cell superantigen. J. Immunol. 157, 1200-1206 (1996).
85. Kozlowski, L. M., Li, W., Goldschmidt, M. & Levinson, A. I. In vivo inflammatory response to a prototypic B cell superantigen: elicitation of an Arthus reaction by staphylococcal protein A. J. Immunol. 160, 5246-5252 (1998).
86. Palmqvist, N., Silverman, G. J., Josefsson, E. & Tarkowski, A. Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus. Microbes Infect. 7, 1501-1511 (2005). First demonstration that SpA mediates B-cell superantigen effects during in vivo infection.
87. H3 heavy chains. J. Clin. Invest. 88, 911-920 (1991).
88. Silverman, G. J. & Rapaport, E. Variable region restriction in circulating human antibodies specific for pneumococcal capsular polysaccharides. FASEBJ. 6, A1223 (1992).
89. Shaw, D. R., Kirkham, P., Schroeder, H. W. J., Roben, P. & Silverman, G. J. Structure-function studies of human monoclonal antibodies to pneumococcus type 3 polysaccharide. Ann. NY Acad. Sci. 764, 370-373 (1995).
90. McKenney, D. et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 284, 1523-1527 (1999).
91. Grimaldi, C. M., Michael, D. J. & Diamond, B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167, 1886-1890 (2001).
92. Silverman, G. J., Goodyear, C. S. & Siegel, D. L. On the mechanism of staphylococcal protein A immunomodulation. Transfusion 45, 274-280 (2005).
93. Sasso, E. H. Immunoglobulin V genes in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 18, 809-836 (1992).
94. 3-binding fragments derived from immunized donors using phage display. J. Immunol. 168, 2035-2045 (2002).
95. Roark, J. H., Bussel, J. B., Cines, D. B. & Siegel, D. L. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood 100, 1388-1398 (2002).
96. Newkirk, M. M. et al. Restricted immunoglobulin variable region gene usage by hybridoma rheumatoid factors from patients with systemic lupus erythematosus and rheumatoid arthritis. Mol. Immunol. 30, 255-263 (1993).
97. Festenstein, H. Immunogenetic and biologic aspects of in vitro lymphocyte allo-transformation (MLR) in the mouse. Transplant Rev. 15, 62 (1973).
98. Marrack, P., Kushnir, E. & Kappler, J. A maternally inherited superantigen encoded by a mammary tumour virus. Nature 349, 524-526 (1991).
99. Cary, S. P., Lee, J., Wagenknecht, R. & Silverman, G. J. Characterization of superantigen-induced clonal deletion with a novel clan III-restricted avian monoclonal antibody: exploiting evolutionary distance to create antibodies specific for a conserved VH region surface. J. Immunol. 164, 4730-4741 (2000).
100. Enever, C., Tomlinson, I. M., Lund, J., Levens, M. & Holliger, P. Engineering high affinity superantigens by phage display. J. Mol. Biol. 347, 107-120 (2005).
101. Goodyear, C. S. & Silverman, G. J. in Protein-Protein Interactions: a molecular cloning manual (ed. Golemis, E.) 143-166 (Cold Spring Harbor Laboratory Press, 2002).
102. Smith, D. et al. Whole-body autoradiography reveals that the Peptostreptococcus magnus immunoglobulin-binding domains of protein L preferentially target B lymphocytes in the spleen and lymph nodes in vivo. Cell Microbiol. 6, 609-623 (2004).